Newark, NJ (February 04, 2016) – NJBIZ, New Jersey’s leading business journal, has selected Dr. Mary Potasek, president of Simphotek, Inc., as one of the state’s most influential women in business.
“I am very honored to be selected for the NJBIZ Best 50 Women in Business,” said Dr. Potasek, a notable researcher, scientist, and Women in STEM advocate with over 35 years of technical and management experience. Dr. Potasek’s illustrious career includes research and development at Columbia University, New York University, Bell Laboratories, and the Air Force Research Laboratory, as well as leadership posts for a $40M telecommunications startup and a photonics based network.
In her current role as president of Simphotek, Inc., a company working on Photodynamic Therapy (PDT) for cancer treatment located at the Enterprise Development Center (EDC) at New Jersey Institute of Technology, Dr. Potasek and her team works with collaborators on a therapy that may revolutionize cancer treatment. Photodynamic Therapy involves lasers for light generation, fiber optics for light delivery to the cancer tumor, and a drug, whose photo-active chemicals kill cancer cells. Simphotek believes its product offers a quantitative treatment protocol, and through computer-based instruments, PDT medical teams will be able to create personalized medicine, reduce operating room personnel costs, expand treatment both nationally and internationally and, most importantly, improve patient survival.
Simphotek is funded in part by the National Cancer Institute and is collaborating with clinical doctors, radiation physicists and cancer biologists at the Hospital and the Medical School of the University of Pennsylvania (Penn). Penn is already engaged in Phase II/III human clinical trials after very successful Phase I clinical trials and animal studies. PDT is in clinical trials throughout the US, EU and Japan in areas such as brain, esophageal, head and neck, lung, prostrate, mesothelioma, gastrointestinal and bile duct cancers.
“Mary is a brilliant mind, and we’re very proud she has chosen to grow her business here at the EDC. Her vision, aptitudes, and knowledge are true gifts to the scientific and business communities of New Jersey and the world” said Jerry Creighton, Sr. executive director of the EDC.
To be eligible for this competitive awards program, NJBIZ looks for women business leaders who are influential in their companies, industries and communities, as well as shaping the economic future of New Jersey.
Dr. Potasek shares the honor with her fellow Simphotek team members Gene Parilov, PhD, Karl Beeson, PhD, and Steve Literati, MBA. All are very excited to be involved in this ground breaking cancer treatment and the visibility presented to the organization through the NJBIZ 50 Best Women in Business contest. Simphotek is also interested in meeting with Angels, Venture Capitalists and Philanthropists to advance this promising area. Please contact firstname.lastname@example.org or visit simphotek.com for more information.